|
Wolfville, NS) – Acadia University chemistry professor, Dr. Amitabh Jha, has received $141,270 from the Nova Scotia Health Research Foundation to assist in developing anticancer agents with the potential to treat cancers unresponsive to current therapies. Many forms of cancers have become drug-resistant and available approaches to treatment often mean considerable side effects for patients
“We have identified a new class of potent anticancer molecules,” says Dr. Jha. “These compounds are markedly divergent in structure from currently available anticancer drugs and may be of value in treating drug-resistant tumors.”
Dr. Jha's research aims to develop a sound laboratory infrastructure where research leading to important advances in cancer chemotherapy will be pursued. He also aspires to develop an infrastructure where new scientists will be trained to develop new drugs, an advancement that will have a major impact on the general well-being of society.
“Acadia’s research base continues to expand and the general area of Health and Wellness is a priority,” says Dr. Thomas Ellis, Dean of Research and Graduate Studies at Acadia. “Dr. Jha’s medicinal chemistry research shows great potential, and we are fortunate to have an organization such as the Nova Scotia Health Research Foundation helping to build research capacity in the province.”
While primary research will be carried out at Acadia University, associated biological studies will be performed in the laboratories of Dr. Jha’s collaborators at Rega Institute of Medical Research (Belgium), Wayne State University (USA), National Cancer Institute (USA), National Institutes of Health (USA), University of Saskatchewan and Dalhousie University.
- 30 -
|
